Equities researchers at StockNews.com initiated coverage on shares of OpGen (NASDAQ:OPGN – Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the medical research company’s stock.
OpGen Price Performance
Shares of NASDAQ:OPGN opened at $1.37 on Thursday. OpGen has a 1-year low of $0.53 and a 1-year high of $9.90. The company’s fifty day moving average is $1.02 and its two-hundred day moving average is $1.61.
About OpGen
Featured Articles
- Five stocks we like better than OpGen
- Golden Cross Stocks: Pattern, Examples and Charts
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- How to Most Effectively Use the MarketBeat Earnings Screener
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Investing in the High PE Growth Stocks
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.